IHH Healthcare ‘on track’ for double-digit ROE despite medical inflation woes
Management says sustained medical inflation in Malaysia will stabilise over time
Add BT as a preferred source
INTEGRATED healthcare operator IHH Healthcare is “on track for double-digit return on equity (ROE)” in the coming years, said its management on Friday (Feb 28).
While the group did not give a concrete timeline for achieving this goal, it has “set itself up for going towards double-digit ROE in 2025 as well”, said group chief financial officer Dilip Kadambi during an earnings call after the release of its FY2024 results.
ROE for FY2024 stood at 8.7 per cent, while ROE without exceptional items and the effects of Malaysian Financial Reporting Standard 129 – the financial reporting standard for hyperinflationary economies – was 9 per cent.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
Japan Home closing outlets; staff say Valu$ taking over operations
Timah Partners lands S$60 million facility from lenders including UOB, RHB
